QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Jonathan M. Pratt
CEOJonathan M. Pratt
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
10.35B
Market cap10.35B
Price-Earnings ratio
25.51
Price-Earnings ratio25.51
Dividend yield
0.70%
Dividend yield0.70%
Average volume
9.34M
Average volume9.34M
High today
$50.40
High today$50.40
Low today
$50.08
Low today$50.08
Open price
$50.35
Open price$50.35
Volume
4.17M
Volume4.17M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

The current QIAGEN(QGEN) stock price is $50.17, with a market capitalization of 10.35B. The stock trades at a price-to-earnings (P/E) ratio of 25.51 and offers a dividend yield of 0.70%.

As of 2026-11-01, QIAGEN(QGEN) stock has fluctuated between $50.08 and $50.40. The current price stands at $50.17, placing the stock +0.2% above today's low and -0.5% off the high.

The QIAGEN(QGEN)'s current trading volume is 4.17M, compared to an average daily volume of 9.34M.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

QGEN News

TipRanks 2d
Millennium International Management Discloses 2.6% Stake in QIAGEN

The latest announcement is out from Qiagen ( (QGEN) ). The Netherlands Authority for the Financial Markets has disclosed that Millennium International Manageme...

Simply Wall St 3d
Qiagen Ties Its Research Story To A Pharma Backed Immune Dataset

Qiagen (NYSE:QGEN) subsidiary Parse Biosciences has partnered with Nomic Bio to create the Cascade multimodal immune response dataset. Cascade combines single...

Analyst ratings

89%

of 18 ratings
Buy
11.1%
Hold
88.9%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.